Synthetic glycoconjugates characterize the fine specificity of Brucella A and M monoclonal antibodies

Abstract

Synthetic oligosaccharide glycoconjugates representing A and M epitopes of<italic>Brucella</italic>bacteria define the fine specificity of five monoclonal antibodies.